Stockreport

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update [Yahoo! Finance]

MiNK Therapeutics, Inc.  (INKT) 
PDF discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated di [Read more]